Form 4 for GTBP GT Biopharma, Inc.
Accepted 2023-04-11 00:00:00 ET · period of report 2023-04-11 · accession 0001493152-23-011888 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-11 | 2023-04-11 | GTBP | Breen Michael Martin | Executive COB, Interim CEO, Dir | P - Purchase | $0.5 | +50.0K | 656.2K | +8% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-11 | P | A | 50,000 | $0.5 | 656,218 | D | — | — |